Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experiment von Schoefs, Elise, Vermeire, Séverine, Ferrante, Marc, Sabino, João, Verstockt, Bram, Avedano, Luisa, De Rocchis, Maria Stella, Sajak-Szczerba, Magdalena, Saldaña, Roberto, Straetemans, Noortje, Vandebroek, Martina, Janssens, Rosanne, Huys, Isabelle

Volltext

Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experiment von Schoefs, Elise, Vermeire, Severine, Ferrante, Marc, Sabino, Joao, Verstockt, Bram, Avedano, Luisa, De Rocchis, Maria Stella, Sajak-Szczerba, Magdalena, Saldana, Roberto, Straetemans, Noortje, Vandebroek, Martina, Janssens, Rosanne, Huys, Isabelle

Volltext

Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies von Fierens, Liselotte, Liefferinckx, Claire, Hoefkens, Eveline, Lobatòn, Triana, Dreesen, Erwin, Sabino, João, Ferrante, Marc

Volltext